Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

79
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
79
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

50
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
50
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

67
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
67
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

55
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
55
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

147
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
147
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

52
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
52

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comment on 'Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy'.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Predicting dialyzer fiber blocking is hard due to high intrapatient variability and limited utility of thrombin generation markers.

Scientific reports·2026
Same author

Lessons in public trust.

Nature medicine·2026
Same author

Use of cystatin C as a marker for estimated glomerular filtration rate in non-kidney transplant recipients.

Transplantation reviews (Orlando, Fla.)·2025
Same author

Deceased Donor Organ Donation in the United States: A Review of Current Practices and Future Directions.

The American surgeon·2025
Same author

Development of a standard process to identify, implement, and validate pharmacist-impacted clinical outcome measures in the acute care setting - part II.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025

Related Experiment Video

Updated: Sep 2, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Evaluating Potentially Inappropriate Medications in Older Kidney Transplant Recipients.

Elizabeth A Cohen1, Lena M DeVietro2, Brock A Richardson3

  • 1From the Department of Pharmacy, Yale New Haven Hospital, New Haven.

Journal of Patient Safety
|August 10, 2022
PubMed
Summary

The Beers Criteria identified more potentially inappropriate medications (PIMs) in older kidney transplant recipients than the STOPP Criteria. STOPP Criteria use led to a decrease in PIMs, while Beers Criteria use showed an increase.

More Related Videos

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.7K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.0K

Related Experiment Videos

Last Updated: Sep 2, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.7K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.0K

Area of Science:

  • Geriatric Pharmacology
  • Nephrology
  • Transplantation Medicine

Background:

  • Potentially inappropriate medications (PIMs) pose risks to older adults.
  • Beers Criteria and Screening Tool of Older Persons' Prescriptions (STOPP) Criteria are key tools for assessing PIMs.

Purpose of the Study:

  • To compare the effectiveness of Beers Criteria and STOPP Criteria in identifying PIMs in older kidney transplant recipients.
  • To evaluate medication changes from admission to discharge using both criteria.

Main Methods:

  • Retrospective chart review of 121 kidney transplant recipients aged 65+.
  • Analysis of PIMs on admission and discharge using Beers and STOPP Criteria.
  • Assessment of 3-month readmissions related to PIMs.

Main Results:

  • Beers Criteria identified 106 PIMs on admission, compared to 60 by STOPP Criteria.
  • STOPP Criteria use resulted in a 38% decrease in PIMs at discharge.
  • Beers Criteria use showed a 9% increase in PIMs at discharge.

Conclusions:

  • Older kidney transplant recipients were more likely to be on Beers Criteria-listed medications.
  • Beers Criteria identified more PIMs on admission and discharge compared to STOPP Criteria.
  • STOPP Criteria demonstrated a greater reduction in PIMs post-transplant.